Author

Peter Holman

Institution: Arsenal Biosciences (United States)

Observed institution: Arsenal Biosciences (United States)

ORCID: 0009-0000-0773-7361

Observed ORCID: 0009-0000-0773-7361

OpenAlex ID: A5113382304

The Cell and Gene Therapy Consortium's Perspective on Harmonizing Data Collection for Patient Enrollment, Therapy Ordering and Scheduling, and Cell Collection

2023 · Alexandra Mora, Linda Barnes, et al. · Transplantation and Cellular Therapy · 8

Risk-Based Qualification of Cellular Starting Material Collection Sites: Tools to Determine Scope of Manufacturer Audits and Reduce Duplicative Efforts

2024 · Peter Holman, Kara Wacker, et al. · Transplantation and Cellular Therapy · 5

Thought leadership in cellular starting material: A review of summary themes from the AABB cellular starting material forums of 2021–2024

2026 · Linda S. Barnes, Priya Baraniak, et al. · Transfusion

Works count: 3

Citation count: 13

H-index: 2

I10-index: